We have demonstrated that longitudinal non-invasive duplexed optical fluorescence imaging provides a simple assessment of arthritic disease activity within the joints of mice following the induction of CIA and may represent a powerful tool to monitor the efficacy of drug treatments in preclinical studies.
are a variety of imaging agents available that may be used to monitor disease activity. The simplest are perhaps nonspecific agents such as the Indocyanine dyes, which injected intravenously, can be used to monitor inflammation as a result of accumulation at sights of increased blood flow and vascular leakage. Indocyanine dyes have been used pre-clinically in rodent arthritis models [3, 4] and clinically in rheumatoid arthritis patients where accumulation of Indocyanine Green fluorescence has been shown to correlate with both magnetic resonance imaging and ultrasound assessments of disease severity [5] [6] [7] . Imaging of this nature offers a technically simple and relatively inexpensive means to monitor disease activity. More information however can be obtained about the underlying disease mechanism by using fluorescent probes that are targeted to specific disease associated molecules or processes. For example, conjugation of fluorochromes to antibodies against F4/80, a marker for macrophages [8] or Ee-selectin, a marker of endothelial cell activation [9] , or the labelling of small molecules such as folate, the accumulation of which has been associated with the increased metabolic activity observed at sites of inflammation [10] .
Reactive probes may also be used to monitor the production of reactive oxygen species [11] , or the activity of inflammation associated enzymes such as cathepsins [12] [13] [14] [15] and matrix metalloproteases (MMPs) [16] [17] [18] [19] [20] . Probes such as luminol, which react with enzymes that are produced by specific cell types, may also be used to monitor the infiltration and activity of those cells into sites of inflammation [21] . More recently, cell death was assessed in collagen-induced arthritis (CIA) by using a near-infrared PSVue 794 dye [22] .
In addition to monitoring inflammatory or autoimmune conditions activatable fluorescent probes have been used successfully to monitor disease and therapeutic efficacy in a variety of cancer models. MMPSense 680 fluorescence has been shown to correlate with the presence of tumours in [23] , while Neutrophil Elastase 680 has been used to monitor neutrophil activity within tumours following photodynamic therapy [24] . Decreases in bone metastasis associated CatK 680 fluorescence has been shown to correlate with successful treatment in a murine model of breast cancer [25] .
Despite one of the major advantages offered by non-invasive imaging being the ability to repeatedly evaluate the molecular processes occurring within arthritic joints over the entire course of the experimental model, the majority of studies to date only look at one or two time points, and in addition only evaluate a single reagent in each animal. In the present study we show the use of four 
Methods

Mice
Male DBA/1 mice were obtained from Harlan Olac (Bicester, UK). All mice were used at 6-7 weeks old and maintained at the Biological Services Unit, University of Glasgow in accordance with Home Office UK guidelines.
Induction of collagen-induced arthritis
On day 0, collagen-induced arthritis was induced under light anaesthesia in DBA/1 male mice by intradermal injection of 200 µg Bovine Type II Collagen (MD Biosciences, St Paul, MN) emulsified in Complete Freund's Adjuvant (Chondrex, Redmond, WA) into the shaved rump followed by a boost on day 21 using 200 µg of Bovine Type II collagen in PBS administered intraperitoneally [26] .
Clinical Scoring regime
Signs of arthritis were assessed in all paws according to a 0-4 scale of ascending severity: 0= No reaction; 1= mild, but definite redness and swelling of the ankle/wrist or apparent redness and swelling limited to individual digits, regardless of the number of digits affected; 2= moderate to severe redness and swelling of the ankle/wrist; 3= Redness and swelling of the entire paw including digits; 4= maximally inflamed limb with involvement of multiple joints [26] . Paw thickness as a measure of swelling was determined in mm three times weekly using dial callipers (Kroeplin, Munich, Germany) [27] , data areis presented as the mean thickness of all four paws. All animals were scored and the paw measurements were taken on the day of imaging.
Probe administration protocol
Four fluorescent probes were used in this study: Neutrophil Elastase 680 FAST, ProSense 750 FAST, CatK 680 FAST and MMPSense 750 FAST (all from PerkinElmer, Llantrisant, UK). Probes 
In vivo Optical Imaging
Images were acquired on a Kodak in vivo imaging system FX Pro (Carestream, Hertfordshire, UK).
Animals were anaesthetised using isoflurane and oxygen and fur removed from the limbs using a depilatory cream (Boots Pharmacy Ltd, UK). Black electrical insulating tape was used to cover the abdomen to reduce nonspecific signal from probes degraded during excretion, and the mouse was 
Histological Scoring
Rear paws were sampled on day 35, fixed in neutral buffered formalin (CellPath Ltd, Powys, UK), decalcified in EDTA, stained with haematoxylin & eosin or toluidine blue (Sigma-Aldrich) [28] , and scored in a blinded fashion as described below [26] . Data is presented as the mean of the sum of the scores obtained for the three parameters obtained for each paw.
For the inflammatory cell infiltrates the scoring system was as follows: 0= no infiltrate detected, 1= modest leukocyte infiltration in synovial tissue, no fluid leukocytes, 2= moderate leukocyte infiltration in synovial tissue and in fluid phase with loss of synovial architecture, 3= gross leukocyte infiltration in synovial membrane and fluid space with significant loss of synovial and articular architecture. For synovial hyperplasia, the scoring system was as follows: 0= no abnormalities detected, 1= synovial lining layer 2-4 cell thick, 2= synovial lining layer >5 cells 
Statistical Analysis
Where appropriate data are expressed as the group mean ± standard error of the mean (SEM).
Statistical significances were determined by students t test using the Winstat™ add in for Excel™.
A P-value of less than 0.05 was taken to be significant. Correlations between the arthritis score, paw measurements, histopathology score and FI were performed using the Spearman Rank Correlation Analysis. A P-value of less than 0.05 was deemed to be significant.
Results
Fluorescence from commercially available activatable probes correlates with clinical disease score in collagen-induced arthritis
As is typically observed in this model, very little disease was observed prior to the second collagen injection on day 21, following this the clinical score increased peaking on day 33 ( Fig. 1A and B) .
The naive groups (n=3) remained disease free throughout the study, excepting a single animal in the Neutrophil Elastase 680 FAST/ProSense 750 FAST treated group which developed a transient score of 1, which was probably a minor injury and consistent with normal activity.
The increase in clinical score observed in the CIA mice was mirrored by the FI from the neutrophil elastase and cathepsin (both the multi cathepsin sensitive ProSense and the cathepsin K specific 9 CatK) sensitive probes (Fig. 1C, D and E) . MMPSense gave the more variable fluorescence in both the naive and the arthritic animals (Fig. 1F) .
Neutrophil Elastase 680 FAST and ProSense 750 FAST were the more sensitive probes, giving the highest degree of correlation between total clinical score and total FI (Fig. 1G and H) . CatK 680 FAST FI, while mirroring the disease induction, was a little less sensitive showing a lower degree of correlation with the clinical score; with an increase in fluorescence above that observed in the naive animals only evident in mice with a total score of >6 (Fig. 1I ). This probably relates to the degree of disease required in the CIA model before bone erosion, resulting from increased osteoclast (and therefore cathepsin K) activity, develops [29, 30] . The lowest degree of correlation with clinical arthritis scores was observed with the fluorescence from MMPSense 750 probe, with an increase in fluorescence above that observed in the naive animals only observed in mice with a total score of >8 (Fig. 1J) .
The probes Neutrophil Elastase 680 FAST and ProSense 750 FAST can be used to monitor the efficacy of a of an anti-inflammatory drug treatment in the CIA model
The highest degree of correlation between score and fluorescence was observed with Neutrophil Elastase 680 FAST and ProSense 750 FAST probes. These two probes were therefore carried forward to test the use of non-invasive imaging to monitor the efficacy of the anti-inflammatory drug, dexamethasone (1 mg/kg/day starting on day 21) in the CIA model.
As previously observed, only mild disease in a few animals developed prior to the boost on day 21, subsequent to the boost clinical scores increased in the vehicle treated animals and continued to do so until the experiment terminated. In the dexamethasone treated mice the mild disease that was observed prior to day 21 resolved and the mean clinical score had returned to 0 by day 27, remaining constant until termination ( Fig. 2A) . Paw thickness was also measured and this closely 
until the end of the experiment compared to the vehicle treated group (Fig. 2B ). Significant correlation was also observed between the clinical scores and paw thickness measurements (Fig.   2C ).
The probe cocktail was administered on days 28 and 35 (prior to and at the disease peak) and the mice imaged after 8 hours. The fluorescence intensities generated by Neutrophil Elastase 680 FAST and by ProSense 750 FAST in the dexamethasone treated CIA mice was significantly reduced compared to the vehicle treated control animals at both 28 and 35 days ( Fig. 2D and E) . Arthritic paws are clearly visible in the pseudo coloured fluorescent image and X-ray overlays from the vehicle treated mice and absent from the dexamethasone treated animals for both Neutrophil
Elastase 680 FAST and for ProSense 750 FAST (Fig. 2F) . In addition to the paws there are fluorescent hot spots apparent in the knee joints of some of the vehicle treated animals (#1, 2, 4, and 6). This suggests the presence of inflammation within the knee joint, which is something that is not possible to score clinically. An additional bright spot is observed in mouse 4 over the abdomen, this signal is due to the urinary excretion of the probe localized in the bladder.
The fluorescence intensities in the paws for both probes were found to correlate significantly with both the clinical score ( Fig. 2G and H) and with paw thicknesses (Fig. 2I and J) . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Supplementary Fig. II ).
Correlation with histopathological scores
As a gold standard measure of disease activity in preclinical arthritis studies, the histological scoring data obtained from rear paws sampled at day 35 was also compared with the fluorescence imaging data. The histopathology score in dexamethasone treated animals was found to be significantly lower than that observed in the vehicle control treated animals (Fig. 3A) . The rear paw histopathology scores were then compared with the rear paw thickness, rear paw clinical scores and with the rear paw FI from both probes. The clinical scores and paw measurements correlated with the histopathology scores ( Fig. 3B and C, respectively) ; a similar degree of correlation was also observed between the FI obtained from Neutrophil Elastase 680 FAST and ProSense 750 FAST ( Fig. 3D and E, respectively) .
Discussion
Increased activity of proteases such as the cathepsins [31] and matrix metalloproteinases (MMPs) [32] and infiltration of inflammatory cells such as neutrophils [33] [14, 15] . In our hands MMPSense 750, a probe with multiple MMP sensitivities showed a relatively high degree of variability and was only able to detect differences between naïve and CIA animals once the disease was comparatively severe.
Interestingly, however, evaluation of inflammatory arthritis in CIA has been recently successfully performed using a fluorogenic MMP-3-specific polymeric probe [20] , and an MMP-3 specific probe has been previously used to discriminate between CIA and naïve animals prior to clinically apparent disease [16] . MMP-12 and MMP-13 specific probes have been shown to correlate with CIA disease activity at early and late phases respectively [36] . shown to correlate with disease severity by being able to detect the disease enhancing properties of circulating fibrocytes [37] . More recently, MMPSense 680 was successfully used to monitor osteoarthritis development in mice, after direct injection of the dye through the patellar ligament into the knee joint cavity [19] . Demonstrating that MMP activity can be successfully assessed by near infrared fluorescence imaging depending on the experimental model and route of administration. The cathepsin K specific probe, CatK FAST 680, also showed a lower degree of sensitivity, only showing increased fluorescencet in animals with higher total clinical disease scores. This may also be reflective of cathepsin K's role in bone homeostasis and erosion [38] and it therefore being present at the highest levels only in the more severely affected animals.
Dexamethasone, a synthetic corticosteroid drug with substantial anti-inflammatory activities, has been shown previously to inhibit the development of experimental arthritis following immunisation with type II collagen [39] [40] [41] . Reflecting the profound anti-arthritic effects of dexamethasone treatment in the CIA model, the fluorescence of the probes Neutrophil Elastase FAST 680 and 
13
ProSense FAST 750 wereare also reduced in treated mice. This is consistent with observations in other disease models where dexamethasone reduces pulmonary neutrophil elastase production and in CIA where another steroid drug prednisolone has been shown to reduce the numbers of neutrophils present within inflamed joints [42] .
The use of activatable probes and whole body imaging for disease monitoring has a number of advantages over the standard methods. Firstly, like clinical scoring, imaging can be used to assess the same animal over multiple time points -limited only by the half-life of the selected probes.
However, unlike a simple clinical score, the activatable probes provide information about the molecular processes occurring within tissues. The standard means of assessing the molecular processes of diseases in both animal models and clinically is assessment of serum titres of biomarkers [43, 44] . While repeated blood sampling is possible in animal models and in human patients, this may not fully reflect what is occurring at the site of pathology. In addition, where a mediator such as neutrophil elastase is localized on or in specific cells, this type of assessment allows the longitudinal monitoring of the infiltration and clearance of a specific cell population on an individual basis. An alternative method is to look for enzyme activity within joints [28, 38] , however this is more difficult in a clinical setting involving the biopsy or surgical removal of tissues and would usually be a terminal procedure in an animal model. Thus repeated sampling from the same individual is not usually possible. Therefore, with the rapid development of new imaging probes, optical imaging may soon offer the possibility to assess a broad range of molecular events in a non-invasive and multiplexed manner.
Most importantly, we have shown correlation between the probe FI and the histological score.
Therefore, the proposed approach may decrease the number of animals required per experiment because tissue damage will not necessarily require evaluation by harvesting joints for histology.
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To address this issue data were pooled from the control CIA mice taken from two experiments at two different time points, 4 weeks and 5 weeks, following primary type II collagen immunisation (difference in clinical score of 4.22) . Analysis of the data by dependent student T test showed that the clinical score (A) significantly (P =0.0003; n=9/group) increased from 4.89 ± 1.03 to 9.11 ± 0.73. Concomitantly, the fluorescent intensity for Neutrophil Elastase 680 FAST (B) increased significantly (P =0.0379; n=9/group). The fluorescent intensity for ProSense 750 FAST (C) also increased, approaching, but not reaching, significance (P =0.0679; n=9/group). When data were analysed by independent student T test (the test to be applied in a real experimental scenario; i.e. for the analysis of two independent groups) the clinical score significantly (P =0.004; n=9/group) increased, as did the fluorescent intensity for both Neutrophil Elastase 680 FAST and ProSense 750 FAST (P =0.021 and P =0.026, respectively; n=9/group). Demonstrating that, although less sensitive than the clinical score, these probes have the potential to detect small differences between groups. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 
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